DENTSPLY SIRONA Inc. ( XRAY Quick Quote XRAY - Free Report) recently expanded its strategic partnership with 3Shape, which marks the next step according to their agreement. This expansion, in turn, currently offers a smooth and secure integration of Dentsply Sirona’s Connect Case Center with 3Shape’s Dental System software. It is worth mentioning that both the companies made an agreement in June 2021 that was aimed at enhancing digital dentistry and oral health. The objective was to lend support to the dental community via the evolution of efficient, streamlined and digitally oriented workflows for dentists and dental technicians. Currently, both the companies are committed toward broadening customer accessibility with regards to a wider range of technology choices. This announcement is likely to provide a boost to DENTSPLY SIRONA’s digital dentistry business line. Significance of the Partnership
Through this collaboration, DENTSPLY SIRONA’s intraoral Primescan and Omnicam scanners can now directly merge with 3Shape’s lab software, thereby providing better workflows as well as patient outcomes.
Image Source: Zacks Investment Research
Highly complex treatments can be effectively planned and executed with the help of integrated hardware and software. Streamlined digital workflows can lead to a better working relationship between labs and their dentist partners.
In September, the company announced a five-year agreement with Smile Train — the world’s largest cleft-focused organization — and a donation of $5 million.
In the same month, DENTSPLY SIRONA unveiled an all-inclusive restage of its Implants business, which included three signature workflows to offer dental professionals with a completely new way of practicing implantology and solutions. Price Performance
Shares of the Zacks Rank #3 (Hold) company have gained 1.8%, compared with the
industry’s growth of 12.1% on a year-to-date basis. Stocks to Consider
Some better-ranked stocks in the broader medical space include
Thermo Fisher Scientific Inc. ( TMO Quick Quote TMO - Free Report) , McKesson Corporation ( MCK Quick Quote MCK - Free Report) and NextGen Healthcare, Inc. . Thermo Fisher surpassed earnings estimates in each of the trailing four quarters, the average surprise being 9.02%. The company currently carries a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Thermo Fisher’s long-term earnings growth rate is estimated at 14%. The company’s earnings yield of 3.7% compares favorably with the industry’s (3.6%). McKesson beat earnings estimates in each of the trailing four quarters, the average surprise being 19.9%. The company currently sports a Zacks Rank #1. McKesson’s long-term earnings growth rate is estimated at 8.9%. The company’s earnings yield of 9.9% compares favorably with the industry’s 3.2%. NextGen Healthcare surpassed earnings estimates in each of the trailing four quarters, the average surprise being 16%. The company currently carries a Zacks Rank of 2. NextGen Healthcare’s long-term earnings growth rate is estimated at 8.5%. The company’s earnings yield of 5.9% compares favorably with the industry’s (4.1%).